Patents by Inventor Fernando Valle

Fernando Valle has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20090075347
    Abstract: The present invention provides methods to enhance production of desired products and increase the growth rate of a bacterial strain by inactivating an endogenous arcA and optionally overexpressing a ppc gene.
    Type: Application
    Filed: July 11, 2008
    Publication date: March 19, 2009
    Inventors: Marguerite A. Cervin, Philippe Soucaille, Donald E. Trimbur, Fernando Valle
  • Publication number: 20080299614
    Abstract: The present invention relates to engineering metabolic pathways in bacterial host cells which results in enhanced carbon flow for the production of ascorbic acid (ASA) intermediates. In particular, the invention relates to increasing the production of ASA intermediates in bacterial cells by enhancing the availability of gluconate resulting from the inactivation of endogenous gluconate transporter genes.
    Type: Application
    Filed: June 18, 2008
    Publication date: December 4, 2008
    Inventors: Timothy C. Dodge, Manoj Kumar, M. Harunur Rashid, Fernando Valle
  • Publication number: 20080293124
    Abstract: The present invention concerns multimeric oxidoreductase complexes which function in the enzymatic conversion of a carbon substrate, said complexes having a dehydrogenase subunit and a cytochrome C subunit. The invention further relates to polynucleotides coding for the multimeric complexes and methods of use thereof.
    Type: Application
    Filed: October 16, 2007
    Publication date: November 27, 2008
    Inventors: Robert M. Caldwell, M. Harunur Rashid, Fernando Valle
  • Publication number: 20080254523
    Abstract: The invention provides methods and host cells for the production of ascorbic acid intermediates. The invention also provides host cells having a modification in a polynucleotide that uncouples the catabolic pathway from the oxidative pathway by deleting the encoding for an endogenous enzymatic activity that phosphorylates D-glucose at its 6th carbon and/or a polynucleotide that has deleted the encoding for endogenous enzymatic activity that phosphorylates D-gluconate at its 6th carbon. Such host cells are used for the production of products, such as, ascorbic acid intermediates. Nucleic acid and amino acid sequences with inactivated enzymatic activity which phosphorylates D-glucose at its 6th carbon and inactivated enzymatic activity which phosphorylates D-gluconate at its 6th carbon are provided.
    Type: Application
    Filed: February 27, 2008
    Publication date: October 16, 2008
    Inventors: Timothy C. Dodge, Fernando Valle
  • Publication number: 20080241898
    Abstract: This invention describes methods for enhancing carbon flow into a pathway of a host cell to enhance the biosynthetic production of compounds therefrom, the host cells being selected based on being phenotypically Pts?/glucose+.Such host cells are capable of transporting glucose without consuming PEP, resulting in conservation of PEP which can be re-directed into the pathway in order to enhance the production of desired compounds along the pathway. Pts?/glucose+ mutants have been shown to be advantageous for the enhanced production of the aromatic amino acids.
    Type: Application
    Filed: October 31, 2007
    Publication date: October 2, 2008
    Inventors: Fernando Valle, Noemi Mejia, Alan Berry
  • Patent number: 7419795
    Abstract: The present invention relates to engineering metabolic pathways in bacterial host cells which results in enhanced carbon flow for the production of ascorbic acid (ASA) intermediates. In particular, the invention relates to increasing the production of ASA intermediates in bacterial cells by enhancing the availability of gluconate resulting from the inactivation of endogenous gluconate transporter genes.
    Type: Grant
    Filed: May 10, 2004
    Date of Patent: September 2, 2008
    Assignee: Danisco A/S, Genencor Division
    Inventors: Timothy C. Dodge, Manoj Kumar, M. Harunur Rashid, Fernando Valle
  • Patent number: 7407780
    Abstract: The invention provides methods for producing products comprising improved host cells genetically engineered to have uncoupled productive and catabolic pathways. In particular, the present invention provides host cells having a modification in nucleic acid encoding an endogenous enzymatic activity that phosphorylates D-glucose at its 6th carbon and/or a modification of nucleic acid encoding an enzymatic activity that phosphorylates D-gluconate at its 6th carbon. Such improved host cells are used for the production of products, such as, ascorbic acid intermediates. Methods for making and using the improved host cells are provided. Nucleic acid and amino acid sequences for glucokinase and gluconokinase are provided.
    Type: Grant
    Filed: November 13, 2006
    Date of Patent: August 5, 2008
    Assignee: Genencor International, Inc.
    Inventors: Timothy C. Dodge, Fernando Valle
  • Publication number: 20080176302
    Abstract: The present invention provides a microorganism useful for biologically producing 1,3-propanediol from a fermentable carbon source at higher yield than was previously known. The complexity of the cofactor requirements necessitates the use of a whole cell catalyst for an industrial process that utilizes this reaction sequence to produce 1,3-propanediol. The invention provides a microorganism with disruptions in specified genes and alterations in the expression levels of specified genes that is useful in a higher yielding process to produce 1,3-propanediol.
    Type: Application
    Filed: March 24, 2008
    Publication date: July 24, 2008
    Applicant: E.I. duPont de Nemours and Company
    Inventors: MARGUERITE A. CERVIN, Philippe Soucaille, Fernando Valle
  • Patent number: 7402415
    Abstract: Recombinant organisms are provided comprising genes encoding a glycerol-3-phosphate dehydrogenase and/or a glycerol-3-phosphatase activity useful for the production of glycerol from a variety of carbon substrates. The organisms further contain disruptions in the endogenous genes encoding proteins having glycerol kinase and glycerol dehydrogenase activities.
    Type: Grant
    Filed: November 18, 2005
    Date of Patent: July 22, 2008
    Assignees: E.I. du Pont de Nemours and Company, Genencor International
    Inventors: Ramesh Nair, Mark S. Payne, Donald E. Trimbur, Fernando Valle
  • Patent number: 7371558
    Abstract: The present invention provides a microorganism useful for biologically producing 1,3-propanediol from a fermentable carbon source at higher yield than was previously known. The complexity of the cofactor requirements necessitates the use of a whole cell catalyst for an industrial process that utilizes this reaction sequence to produce 1,3-propanediol. The invention provides a microorganism with disruptions in specified genes and alterations in the expression levels of specified genes that is useful in a higher yielding process to produce 1,3-propanediol.
    Type: Grant
    Filed: October 6, 2003
    Date of Patent: May 13, 2008
    Assignees: E.I. du Pont de Nemours and Company, Genencor International
    Inventors: Marguerite A. Cervin, Phillipe Soucaille, Fernando Valle
  • Publication number: 20080076678
    Abstract: The present invention relates to a method of creating DNA libraries that include an artificial promoter library and/or a modified ribosome binding site library and transforming bacterial host cells with the library to obtain a population of bacterial clones having a range of expression levels for a chromosomal gene of interest.
    Type: Application
    Filed: November 19, 2007
    Publication date: March 27, 2008
    Inventors: Philippe SOUCAILLE, Marguerite CERVIN, Fernando VALLE
  • Publication number: 20070298474
    Abstract: A method for enhancing a host cell's biosynthetic production of 2-KLG is described. Such method comprises selecting a host cell that has an at least partially intracellular synthetic pathway which utilizes 2,5-DKG to produce 2-KLG; increasing the transport of said 2,5-DKG into said host cell while maintaining the integrity of the host cell; culturing the host cell to produce said 2,5-DKG; and producing 2-KLG. The transport of the 2,5-DKG is increased by transforming into the host cell DNA encoding for one or more enzymes transporting the 2,5-DKG into the host cell.
    Type: Application
    Filed: July 16, 2007
    Publication date: December 27, 2007
    Inventors: Manoj Kumar, Fernando Valle, Veronique Dartois, James Hoch
  • Publication number: 20070184540
    Abstract: The present invention relates to a method of altering bacterial host cells to accumulate 2-keto-D-gluconic acid (2-KDG) by inactivating an endogenous membrane bound 2-keto-D-gluconate dehydrogenase (2-KDGDH), which prior to inactivation catalyzed the conversion of 2-KDG to 2,5-diketogluconate (2,5-DKG).
    Type: Application
    Filed: April 2, 2007
    Publication date: August 9, 2007
    Inventors: Timothy Dodge, M. Rashid, Fernando Valle
  • Patent number: 7241587
    Abstract: The invention provides methods for producing products comprising improved host cells genetically engineered to have uncoupled productive and catabolic pathways. In particular, the present invention provides host cells having a modification in nucleic acid encoding an endogenous enzymatic activity that phosphorylates D-glucose at its 6th carbon and/or a modification of nucleic acid encoding an enzymatic activity that phosphorylates D-gluconate at its 6th carbon. Such improved host cells are used for the production of products, such as, ascorbic acid intermediates. Methods for making and using the improved host cells are provided. Nucleic acid and amino acid sequences for glucokinase and gluconokinase are provided.
    Type: Grant
    Filed: April 4, 2002
    Date of Patent: July 10, 2007
    Assignee: Genencor International, Inc.
    Inventors: Timothy C. Dodge, Fernando Valle
  • Patent number: 7229811
    Abstract: The invention provides isolated nucleic acid molecules encoding polypeptides having 2,5-DKG permease activity, and oligonucleotides therefrom. The isolated nucleic acid molecules can be expressed in appropriate bacterial cells to enhance the production of 2-KLG, which can subsequently be converted to ascorbic acid. Further provided are isolated polypeptides having 2,5-DKG permease acitivity, immunogenic peptides therefrom, and antibodies specific therefor. The invention also provides methods of identifying novel 2,5-DKG permeases.
    Type: Grant
    Filed: August 3, 2001
    Date of Patent: June 12, 2007
    Assignees: Genencor International, Inc., E.P.I. Liquidation Co.
    Inventors: Manoj Kumar, Fernando Valle, Veronique A. Dartois, James A. Hoch
  • Patent number: 7229795
    Abstract: The invention provides isolated nucleic acid molecules encoding polypeptides having 2,5-DKG permease activity, and oligonucleotides therefrom. The isolated nucleic acid molecules can be expressed in appropriate bacterial cells to enhance the production of 2-KLG, which can subsequently be converted to ascorbic acid. Further provided are isolated polypeptides having 2,5-DKG permease activity, immunogenic peptides therefrom, and antibodies specific therefor. The invention also provides methods of identifying novel 2,5-DKG permeases.
    Type: Grant
    Filed: February 25, 2004
    Date of Patent: June 12, 2007
    Assignees: Genencor International, Inc., E.P.I. Liquidation Co.
    Inventors: Veronique A. Dartois, James A. Hoch, Fernando Valle, Manoj Kumar
  • Publication number: 20070059811
    Abstract: The invention provides methods for producing products comprising improved host cells genetically engineered to have uncoupled productive and catabolic pathways. In particular, the present invention provides host cells having a modification in nucleic acid encoding an endogenous enzymatic activity that phosphorylates D-glucose at its 6th carbon and/or a modification of nucleic acid encoding an enzymatic activity that phosphorylates D-gluconate at its 6th carbon. Such improved host cells are used for the production of products, such as, ascorbic acid intermediates. Methods for making and using the improved host cells are provided. Nucleic acid and amino acid sequences for glucokinase and gluconokinase are provided.
    Type: Application
    Filed: November 13, 2006
    Publication date: March 15, 2007
    Inventors: Timothy Dodge, Fernando Valle
  • Publication number: 20060286653
    Abstract: Recombinant organisms are provided comprising genes encoding a glycerol-3-phosphate dehydrogenase and/or a glycerol-3-phosphatase activity useful for the production of glycerol from a variety of carbon substrates. The organisms further contain disruptions in the endogenous genes encoding proteins having glycerol kinase and glycerol dehydrogenase activities.
    Type: Application
    Filed: November 18, 2005
    Publication date: December 21, 2006
    Inventors: Ramesh Nair, Mark Payne, Donald Trimbur, Fernando Valle
  • Patent number: 7132527
    Abstract: This invention provides a series of low-copy number plasmids comprising restriction endonuclease recognition sites useful for cloning at least three different genes or operons, each flanked by a terminator sequence, the plasmids containing variants of glucose isomerase promoters for varying levels of protein expression. The materials and methods are useful for genetic engineering in microorganisms, especially where multiple genetic insertions are sought.
    Type: Grant
    Filed: December 18, 2003
    Date of Patent: November 7, 2006
    Assignee: E. I. du Pont de Nemours and Company
    Inventors: Mark S. Payne, Stephen K. Picataggio, Amy Kuang-Hsu, Ramesh V. Nair, Fernando Valle, Philippe Soucaille, Donald E. Trimbur
  • Publication number: 20060246562
    Abstract: Recombinant organisms are provided comprising genes encoding cob(II)alamin reductase, cob(I)alamin adenosyltransferase, glycerol dehydratase and 1,3-propanediol oxidoreductase activities useful for the production of 1,3-propanediol from a variety of carbon substrates.
    Type: Application
    Filed: June 29, 2006
    Publication date: November 2, 2006
    Inventors: Nigel Dunn-Coleman, Anthony Gatenby, Fernando Valle